{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:30:35Z","timestamp":1791199835656,"version":"4.2.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ecl.2022.07.003","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T17:08:23Z","timestamp":1668445703000},"page":"27-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes"],"prefix":"10.1016","volume":"52","author":[{"given":"Shuai","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanicia","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyathama","family":"Vellanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ecl.2022.07.003_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2021.11165","article-title":"Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017","volume":"326","author":"Lawrence","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ecl.2022.07.003_bib3","doi-asserted-by":"crossref","first-page":"e194498","DOI":"10.1001\/jamapediatrics.2019.4498","article-title":"Prevalence of prediabetes among adolescents and young adults in the United States, 2005-2016","volume":"174","author":"Andes","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"11","key":"10.1016\/j.ecl.2022.07.003_bib4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease","volume":"44","year":"1995","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.ecl.2022.07.003_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/00325481.2020.1771047","article-title":"Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications","volume":"132","author":"Wysham","year":"2020","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1016\/j.ecl.2022.07.003_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-5448.2012.00915.x","article-title":"Progressive deterioration of beta-cell function in obese youth with type 2 diabetes","volume":"14","author":"Bacha","year":"2013","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"10.1016\/j.ecl.2022.07.003_bib7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/dc12-2393","article-title":"Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and beta-cell function in TODAY","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ecl.2022.07.003_bib8","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","article-title":"Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ecl.2022.07.003_bib9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","article-title":"Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure","volume":"150","author":"Talchai","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ecl.2022.07.003_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/10.1210\/er.2006-0038","article-title":"Beta-cell failure in diabetes and preservation by clinical treatment","volume":"28","author":"Wajchenberg","year":"2007","journal-title":"Endocr Rev"},{"issue":"Suppl 3","key":"10.1016\/j.ecl.2022.07.003_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1463-1326.2012.01658.x","article-title":"Short-term intensified insulin treatment in type 2 diabetes: long-term effects on beta-cell function","volume":"14","author":"Retnakaran","year":"2012","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.ecl.2022.07.003_bib12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","article-title":"Understanding the mechanisms of reversal of type 2 diabetes","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ecl.2022.07.003_bib13","doi-asserted-by":"crossref","DOI":"10.2337\/dci21-0034","article-title":"Consensus report: definition and interpretation of remission in type 2 diabetes","author":"Riddle","year":"2021","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ecl.2022.07.003_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cmet.2014.03.010","article-title":"Pancreatic beta cell dedifferentiation in diabetes and redifferentiation following insulin therapy","volume":"19","author":"Wang","year":"2014","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.ecl.2022.07.003_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s42255-020-0171-3","article-title":"Targeted pharmacological therapy restores beta-cell function for diabetes remission","volume":"2","author":"Sachs","year":"2020","journal-title":"Nat Metab"},{"issue":"11","key":"10.1016\/j.ecl.2022.07.003_bib16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.metabol.2011.01.018","article-title":"Insulin improves beta-cell function in glucose-intolerant rat models induced by feeding a high-fat diet","volume":"60","author":"Li","year":"2011","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.ecl.2022.07.003_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S2213-8587(13)70006-8","article-title":"Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"1","author":"Kramer","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2022.07.003_bib18","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2337\/diacare.27.11.2597","article-title":"Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function","volume":"27","author":"Li","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ecl.2022.07.003_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diabres.2006.07.001","article-title":"The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment","volume":"75","author":"Chen","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"10.1016\/j.ecl.2022.07.003_bib20","first-page":"1878","article-title":"[Effect of short-term intensive treatment with insulin pump on beta cell function and the mechanism of oxidative stress in newly diagnosed type 2 diabetic patients]","volume":"27","author":"Zhao","year":"2007","journal-title":"Nan Fang Yi Ke Da Xue Xu Bao"},{"issue":"3","key":"10.1016\/j.ecl.2022.07.003_bib21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/dc11-1638","article-title":"Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment","volume":"35","author":"Chen","year":"2012","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ecl.2022.07.003_bib22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1089\/dia.2012.0055","article-title":"Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy","volume":"14","author":"Liu","year":"2012","journal-title":"Diabetes Technol Ther"},{"issue":"9626","key":"10.1016\/j.ecl.2022.07.003_bib23","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on \u03b2-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ecl.2022.07.003_bib24","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2337\/dc08-0075","article-title":"Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy","volume":"31","author":"Chen","year":"2008","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ecl.2022.07.003_bib25","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/dom.14421","article-title":"Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): a 2-year randomized controlled trial","volume":"23","author":"Retnakaran","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.ecl.2022.07.003_bib26","doi-asserted-by":"crossref","first-page":"E1398","DOI":"10.1152\/ajpendo.00447.2013","article-title":"Determinants of reversibility of beta-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes","volume":"305","author":"Kramer","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2022.07.003_bib27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/dom.13196","article-title":"Long-term effects on glycaemic control and beta-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: a multicentre randomized trial","volume":"20","author":"Chon","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.ecl.2022.07.003_bib28","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc11-2170","article-title":"Beta-cell function preservation after 3.5 years of intensive diabetes therapy","volume":"35","author":"Harrison","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ecl.2022.07.003_bib29","doi-asserted-by":"crossref","first-page":"e000270","DOI":"10.1136\/bmjdrc-2016-000270","article-title":"Predictors of sustained drug-free diabetes remission over 48\u00a0weeks following short-term intensive insulin therapy in early type 2 diabetes","volume":"4","author":"Kramer","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"5","key":"10.1016\/j.ecl.2022.07.003_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/dme.12671","article-title":"Clinical predictors and time course of the improvement in beta-cell function with short-term intensive insulin therapy in patients with type 2 diabetes","volume":"32","author":"Stein","year":"2015","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.ecl.2022.07.003_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.diabres.2015.02.011","article-title":"Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission","volume":"108","author":"Liu","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.ecl.2022.07.003_bib32","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/dom.13236","article-title":"Two-year trial of intermittent insulin therapy vs metformin for the preservation of beta-cell function after initial short-term intensive insulin induction in early type 2 diabetes","volume":"20","author":"Retnakaran","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.ecl.2022.07.003_bib33","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1210\/jc.2016-3373","article-title":"Piloting a remission strategy in type 2 diabetes: results of a randomized controlled trial","volume":"102","author":"McInnes","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2022.07.003_bib34","first-page":"105","article-title":"Remission of type 2 diabetes following a short-term intervention with insulin glargine, metformin, and dapagliflozin","author":"McInnes","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2022.07.003_bib35","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/db10-1392","article-title":"Effects of rosiglitazone, glyburide, and metformin on beta-cell function and insulin sensitivity in ADOPT","volume":"60","author":"Kahn","year":"2011","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ecl.2022.07.003_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W","article-title":"UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group","volume":"15","author":"Matthews","year":"1998","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.ecl.2022.07.003_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa2100165","article-title":"Long-term complications in youth-onset type 2 diabetes","volume":"385","author":"Study Group","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2022.07.003_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/pedi.12264","article-title":"Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study","volume":"17","author":"Kelsey","year":"2016","journal-title":"Pediatr Diabetes"},{"issue":"24","key":"10.1016\/j.ecl.2022.07.003_bib39","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A\u00a0clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"366","author":"Study Group","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ecl.2022.07.003_bib40","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc15-0848","article-title":"HbA1c after a short period of monotherapy with metformin identifies durable glycemic control among adolescents with type 2 diabetes","volume":"38","author":"Zeitler","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2022.07.003_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/pedi.13325","article-title":"Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: a Pediatric Diabetes Consortium study","author":"Wolf","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"10.1016\/j.ecl.2022.07.003_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pcd.2011.11.001","article-title":"Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes?","volume":"6","author":"Low","year":"2012","journal-title":"Prim Care Diabetes"},{"issue":"8","key":"10.1016\/j.ecl.2022.07.003_bib43","first-page":"1670","article-title":"Effects of treatment of impaired glucose tolerance or recently diagnosed type 2 diabetes with metformin alone or in combination with insulin glargine on beta-cell function: comparison of responses in youth and adults","volume":"68","author":"Consortium Investigators","year":"2019","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.ecl.2022.07.003_bib44","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2337\/dc18-0244","article-title":"Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic clamp","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.ecl.2022.07.003_bib45","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1007\/s11695-017-2866-4","article-title":"The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis","volume":"27","author":"Sheng","year":"2017","journal-title":"Obes Surg"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852922000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852922000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:40Z","timestamp":1760176060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852922000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0889852922000731"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2022.07.003","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2022.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}